Table 1.
Study population
| patient | gender/age | HHV7 (copies/mL) | CSF/serum HHV-7 copies | CSF -WBC | CSF -CSF– polyclonal bands | CSF -CSF– polyclonal oligoclonal | anti-MOG | BBB damage | diagnosis |
|---|---|---|---|---|---|---|---|---|---|
| 1 | F; 9.4 y | 72 | 0.18 | 36 | Yes | none | none | none | meningoencephalitis (ADEM) |
| 2 | F; 1.7 y | 1080 | 0.13 | 5 | yes | none | none | none | encephalitis |
| 3 | F; 11 y | 1500 | 0.8 | 90 | none | yes | none | none | meningoencephalitis |
| 4 | M; 16.2 y | 3500 | 4.87 | / | / | / | / | meningoencephalitis | |
| 5 | M; 9.1 y | 40 | 0.4 | 26 | none | none | yes | meningoencephalitis (AHEM) | |
| 6 | F; 12.6 y | 100 | / | neg | yes | none | none | none | meningoencephalitis with III cranial nerve palsy |
| 7 | M; 8.2 | 100 | 0.058 | 60 | none | none | yes | none | meningoencephalitis (CIS anti-MOG +) |
| 8 | F; 7 y | 40 | 0.23 | neg | / | / | / | / | neuropsychiatric symptoms |
| 9 | M; 14.4 y | 20 | 0.0014 | neg | / | / | / | / | neuropsychiatric symptoms (PANS) |
| 10 | M; 13.6 y | 60 | / | neg | yes | none | none | none | neuropsychiatric symptoms (PANS) |
| 11 | F; 2 y | 33 | 0.825 | neg | yes | none | none | none | neuropsychiatric symptoms |
| 12 | M; 9.5 y | 20 | 0.04 | neg | / | / | / | / | neuropsychiatric symptoms (PANS) |